Systematic characterization of m6A proteomics across 12 cancer types: a multi-omics integration study-Reference-Cited by-同舟云学术

Systematic characterization of m6A proteomics across 12 cancer types: a multi-omics integration study

Published:2024 Issue: Volume: Page:
ISSN:2515-4184
Container-title:Molecular Omics
language:en
Short-container-title:Mol. Omics

Author:

Li Hongru¹^ORCID,Jiang Yunke¹,Chen Jiajin¹²,Li Zaiming¹,Zhang Ruyang¹³,Wei Yongyue¹³,Zhao Yang¹⁴,Shen Sipeng¹²³,Chen Feng¹²

Affiliation:

1. Department of Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China

2. Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, 211166, Nanjing, China

3. China International Cooperation Center of Environment and Human Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China

4. Key Laboratory of Biomedical Big Data of Nanjing Medical University, Nanjing 211166, China

Abstract

The modification patterns of N6-methyladenosine (m6A) regulators and interacting genes are deeply involved in tumors.

Funder

National Natural Science Foundation of China

Natural Science Research of Jiangsu Higher Education Institutions of China

International Cooperation and Exchange Programme

Publisher

Royal Society of Chemistry (RSC)

Subject

Genetics,Molecular Biology,Biochemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2024/MO/D3MO00171G

Reference49 articles.

1. Identification of Methylated Nucleosides in Messenger RNA from Novikoff Hepatoma Cells

2. N6-methyladenosine marks primary microRNAs for processing

3. m6A RNA methylation promotes XIST-mediated transcriptional repression

4. N6-methyladenosine-dependent regulation of messenger RNA stability

5. m6A mRNA methylation regulates CTNNB1 to promote the proliferation of hepatoblastoma